The results of immunofluorescence labeling showed that the proportion of CD163 in RCC tissues was about 2 folds higher than that in normal renal tissues (P< 0.0001), which meant that the proportion of M2 macrophages in RCC tissues increased (Figure 1A). The gene discussed is CD163; the disease is renal cell carcinoma.